UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
SOLICITATION/RECOMMENDATION STATEMENT
UNDER SECTION 14(d)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 9)
| CONVIO, INC. |
(Name of Subject Company)
| CONVIO, INC. |
(Name of Person(s) Filing Statement)
| Common Stock, par value $0.001 per share |
(Title of Class of Securities)
| 21257W 105 (Common Stock) |
(CUSIP Number of Class of Securities)
Gene Austin President and Chief Executive Officer 11501 Domain Drive, Suite 200 Austin, Texas 78758 (512) 652-2600 |
(Name, address and telephone number of person authorized to receive
notice and communications on behalf of the person(s) filing statement).
| With a Copy to: |
John J. Gilluly, Esq.
DLA Piper LLP (US)
401 Congress, Suite 2500
Austin, Texas 78701
(512) 457-7000
| ¨ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Introduction
This Amendment No. 9 amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 initially filed with the Securities and Exchange Commission (the “SEC”) on January 25, 2012 (the “Schedule 14D-9”) by Convio, Inc., a Delaware corporation (the “Company” or “Convio”), and amended on January 31, 2012, February 7, 2012, February 17, 2012, March 7, 2012, March 21, 2012, April 4, 2012, April 13, 2012 and April 18, 2012 relating to the tender offer by Caribou Acquisition Corporation, a Delaware corporation (“Purchaser”), which is a wholly-owned subsidiary of Blackbaud, Inc. (“Blackbaud” or “Parent”), to purchase all issued and outstanding shares of common stock, par value $0.001 per share of the Company (“Common Stock”) at a purchase price of $16.00 per share, payable net to seller in cash, without interest (the “Offer Price”). The tender offer is disclosed in the Tender Offer Statement on Schedule TO (together with any exhibits thereto, as it may be amended and/or supplemented, the “Schedule TO”), filed by Purchaser and Parent with the SEC on January 25, 2012, and is upon the terms and subject to the conditions set forth in the Offer to Purchase dated January 25, 2012 (as it may be amended and/or supplemented, the “Offer to Purchase”), and in the related Letter of Transmittal (as it may be amended and/or supplemented, the “Letter of Transmittal” and, together with the Offer to Purchase, the “Offer”). The Offer to Purchase and the Letter of Transmittal are filed as Exhibits (a)(1)(A) and (a)(1)(B) to the Schedule TO, respectively, and are incorporated herein by reference. Any capitalized term used and not otherwise defined herein shall have the meaning ascribed to such term in the Schedule 14D-9.
Except as otherwise set forth below, the information in the Schedule 14D-9 remains unchanged and is incorporated by reference as relevant to the items in this Amendment No. 9. This Amendment No. 9 is being filed to reflect certain updates as reflected below.
| Item 8. | Additional Information |
Item 8 of the Schedule 14D-9 is hereby amended and supplemented by inserting the following paragraph as the final paragraph under the heading “Antitrust”:
“On April 25, 2012, the Antitrust Division notified the Company that the antitrust investigation of the proposed Merger was closed. The waiting period applicable to the purchase of the Tender Shares pursuant to the Offer is scheduled to expire at 11:59 p.m., New York City time, on April 30, 2012, unless earlier terminated by the FTC and the Antitrust Division.”
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| By: | /s/ James R. Offerdahl | |
| Name: | James R. Offerdahl | |
| Title: | Chief Financial Officer | |
| Dated: | April 26, 2012 | |